유방암의 감시림프절 생검에서 적절한 위음성률을 확보하기 위해 필요한 림프절 개수 = The Number of Removed Lymph Nodes for an Acceptable False Negative Rate in Sentinel Lymph Node Biopsy for Breast Cancer

다국어 초록 (Multilingual Abstract)

Purpose: This study was performed to find the adequate number of removed lymph nodes to achieve an acceptable false-negative rate when performing sentinel lymph node biopsy for breast cancer. Methods: A total of 179 sentinel
node biopsies combined with conventional axillary lymph node dissection for breast cancer were performed between November 2003 and June 2007. Results: The overall identification rate of sentinel lymph node and the false negative rate of the biopsy were 95.0% and 8.1%, respectively. Yet the false negative rate of the biopsy was lowered as the number of the removed nodes was increased. Especially, the false negative rate was 0% when more than 4 lymph nodes were removed. Conclusion: We recommend that four lymph
nodes should be removed to obtain accurate results in sentinel node biopsy for breast cancer.

참고문헌 (Reference)

1 손병호, "임상적으로 림프절 전이를 보이지 않는 유방암 환자에서 방사성 동위원소를 이용한 감시림프절 생검의 성적" 한국유방암학회 10 (10): 141-146, 2007

2 Morton DL, "Will the true sentinel node please stand?" 6 : 12-14, 1999

3 Nathanson SD, "Will the true sentinel node please stand?" 6 : 514-516, 1999

4 Krag D, "The sentinel node in breast cancer--a multicenter validation study" 339 : 941-946, 1998

5 McCarter MD, "The breast cancer patient with multiple sentinel nodes: when to stop?" 192 : 692-697, 2001

6 Morton DL, "Technical details of intraoperative lymphatic mapping for early stage melanoma" 127 : 392-399, 1992

7 Smith LF, "Subareolar injection is a better technique for sentinel lymph node biopsy" 180 : 434-437, 2000

8 Zavagno G, "Subareolar injection for sentinel lymph node location in breast cancer" 28 : 701-704, 2002

9 Bauer TW, "Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer" 9 : 169-176, 2002

10 Veronesi U, "Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes" 349 : 1864-1867, 1997

11 Boxen I, "Sentinel node detection and definition may depend on the imaging agent and timing" 24 : 390-394, 1999

12 Woznick A, "Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal?" 191 : 330-333, 2006

13 Wong SL, "Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate" 192 : 684-689, 2001

14 McMasters KM, "Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used" 18 : 2560-2566, 2000

15 Ikeda T, "Recent development of sentinel lymph node biopsy for breast cancer in Japan" 27 : 275-278, 2004

16 Kim SW, "Prospective study of 162 sentinel lymph node biopsies in breast cancer: usefulness of ultrasonography in patients selection" 6 : 103-108, 2003

17 de Mascarel I, "Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up" 66 : 523-527, 1992

18 Schwartz GF, "Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast April 19 to 22, 2001, Philadelphia, Pennsylvania" 33 : 579-589, 2002

19 Martin RC 2nd, "Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multiinstitutional study. For the University of Louisville Breast Cancer Study Group" 128 : 139-144, 2000

20 Fisher B, "Number of lymph nodes examined and the prognosis of breast carcinoma" 131 : 79-88, 1970

21 Cox CE, "Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: the Moffitt experience" 11 : 222-226, 2004

22 Schrenk P, "Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma" 88 : 608-614, 2000

23 Yi M, "How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?" 113 : 30-37, 2008

24 Martin RC, "Highest isotope count does not predict sentinel node positivity in all breast cancer patients" 8 : 592-597, 2001

25 Estourgie SH, "Eight false negative sentinel node procedures in breast cancer: what went wrong?" 29 : 336-340, 2003

26 Hoon DS, "Detection of metastatic breast cancer by beta-hCG polymerase chain reaction" 69 : 369-374, 1996

27 Noguchi S, "Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification" 148 : 649-656, 1996

28 Cody HS 3rd, "Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures" 8 : 13-19, 2001

29 Hoar FJ, "A prospective study of the value of axillary node sampling in addition to sentinel lymph node biopsy in patients with breast cancer" 29 : 526-531, 2003